-Olon, international API provider, publishes the new 2022 Sustainability Report confirming the progress of its sustainability in the areas of environment, supply chain, people, commitment to the community and production
“Our ambition is to promote a more sustainable production of APIs, complying with the highest quality standards. To achieve this, we are investing in people, in innovation and technology processes, supporting the sustainable development objectives proposed by the 2030 Agenda of the UN” commented Paolo Tubertini, CEO of the Group.
MILAN, Nov. 21, 2022 /PRNewswire/ — Olon, an international API provider, is proud to release its 2022 Annual Corporate Sustainability Report, detailing the company’s global commitment to people, planet and communities in the ones that operate The report describes the substantial progress made in the areas of focus: reducing the environmental footprint, creating a sustainable global supply chain, including the diversity of people, engaging communities and stakeholders, and promoting the processes of more advanced and sustainable manufacturing.
“Following the publication in 2021 of our first Sustainability Manifesto, this is a clear policy and statement document that represents that we are pursuing our vision of sustainable growth. It is an assumption of responsibility towards customers, partners and employees. Our vision is to be a world leader in the production of APIs from a business, social and ethical perspective. We will continue to introduce new initiatives to fulfill our future ambitions”, commented Paolo Tubertini.
You can see the full report here: link
Olon Group is a world leader in the development and production of generic and CDMO active pharmaceutical ingredients, a trusted and preferred partner for the pharmaceutical, biotech and specialty ingredient markets. With a turnover in 2021 of 580 million dollars, OLON supplies 300 APIs for the generic market.
Thanks to its 2,300 employees and its highly qualified R&D team -more than 300 people-, OLON can offer complete and integrated packages and services to support the complete development of APIs, based on a solid knowledge of the chemical and biological process, all under full cGMP and regulatory coverage – holder of some 160 active US DMFs and 79 granted CoS.
Headquartered in Rh̫ne (Milan, Italy), OLON has 11 manufacturing facilities Р8 located in Italy, 1 in Spain, 1 in the US and 1 in India, designed according to the most stringent international requirements, and 3 branches in Hamburg (Germany), Florham Park NJ (USA) and Shanghai (China).
PDF – linkLogo – link
View original content: enlace
